Skip to main content
Premium Trial:

Request an Annual Quote

DoubleTwist Lays Off 20, Promotes Two in Attempt to Streamline Operations

NEW YORK, March 6 – DoubleTwist spokeswoman Nicole Litchfield said Tuesday the company laid off “around 20 people” last week, approximately 10 percent of its staff.

Litchfield said the layoffs were “part of a reorganization to gain efficiency after hiring about 120 people last year.”    

The layoffs were applied equally across the company, Litchfield said. DoubleTwist does not plan any further consolidations.

As part of the reorganization, Robert Williamson, formerly COO, was promoted to president and COO, and Edward Kiruluta, formerly vice president of R&D, was promoted to CTO.    

DoubleTwist filed for an IPO in September, but has since delayed its plans. “We have not withdrawn our IPO,” Litchfield said, “but naturally we're examining all of our options in light of the current financial markets.” 

The layoffs follow closely behind NetGenics’ decision to slash its workforce by 30 percent under similar circumstances.

According to DoubleTwist’s most recent filing with the SEC, an amended S-1 filed November 9, the company’s cash, cash equivalents, and marketable securities were $24.1 million as of September 30.     

For the last nine months of 2000, the last period for which information is available, DoubleTwist’s revenues totaled $4.8 million.

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.